Ouro Medicines is a clinical-stage biotechnology company based in South San Francisco, California, defining the future of treatment for people with immune-mediated diseases. Its pipeline centers on T cell engager programs for autoimmune conditions, including the lead candidate OM336 (evaluated in the AIC-1001 clinical trial), alongside an expanded… - View it on GitHub